#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glomerulonephritis membranoproliferative Progressive multifocal leukoencephalopathy Wiskott-Aldrich syndrome Glomerulonephritis Cognitive disorder Peripheral primitive neuroectodermal tumour of soft tissue Small intestine leiomyosarcoma Malignant neoplasm of choroid Synovial sarcoma metastatic Small cell lung cancer limited stage Angelman's syndrome Leiomyosarcoma recurrent Type IIa hyperlipidaemia Thrombotic microangiopathy Dermatitis More trials…

    Learn about Rare Diseases

    Glycogen storage disease type V – Diagnostics Alport’s syndrome Alagille syndrome Gastrointestinal stromal tumour – Trials in Disease Angiosarcoma – Treatment Angiosarcoma non-metastatic Methylmalonic acidaemia – Treatment Marginal zone lymphoma – Treatment Encephalitis autoimmune Atypical teratoid/rhabdoid tumour of CNS – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gen1053 L-Lysine Acetate Utreglutide Ibrutinib Florbetaben (18F) Indacaterol Maleate Vsf1.01 Dapirolizumab Pegol Empasiprubart Simoctocog Alfa Dydrogesterone Selinexor Tenofovir Disoproxil Fumarate Pelareorep HRS 9531 Tamsulosin Hydrochloride Clavulanic Acid Bhv-7000 Pimecrolimus Meglumine Gadoterate More therapies…

    Learn about Your Condition

    VEXAS syndrome Restless legs syndrome Multiple sclerosis Fibromyalgia Breast cancer recurrent Myositis Diphtheria Oesophagogastroscopy Piriformis syndrome Diabetic ketoacidosis Rhabdomyosarcoma Coronary artery occlusion Craniocerebral injury Chronic coronary syndrome Persistent depressive disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on the Safety and Effectiveness of TAK-755 (Apadamtase Alfa) for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Thrombotic thrombocytopenic purpura
    Investigated Drugs:
    • Apadamtase Alfa
    Austria France Germany Italy Poland Spain

  • Study on the Safety and Effectiveness of Ivosidenib or Enasidenib with Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia with IDH1 or IDH2 Mutations

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Enasidenib Mesilate
    • Ivosidenib
    • Azacitidine
    France Germany Italy The Netherlands

  • Safety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Efgartigimod Alfa
    Bulgaria Greece Italy Norway Portugal Romania

  • Study of Belimumab with Rituximab and Venetoclax for Patients with Refractory or Relapsed Chronic Lymphocytic Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Belimumab
    Germany

  • Long-term Safety and Efficacy Study of Elivaldogene Autotemcel for Patients with Cerebral Adrenoleukodystrophy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Elivaldogene Autotemcel
    France Germany Italy The Netherlands

  • Study on the Effectiveness and Safety of Mitapivat for Patients with Non-Transfusion-Dependent Alpha or Beta Thalassemia

    Not recruiting

    3 1
    Investigated Diseases:
    • Thalassaemia
    Investigated Drugs:
    • Mitapivat
    Bulgaria Denmark France Greece Italy The Netherlands +1
Previous Page
1 … 49 50 51 52 53 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!